azerbaijan pharmaceutical market 2010

4
AZERBAIJAN:in prospect April 2011

Upload: vyazyonova

Post on 24-May-2015

1.656 views

Category:

News & Politics


0 download

DESCRIPTION

Azerbaijan pharmaceutical market 2010

TRANSCRIPT

Page 1: Azerbaijan pharmaceutical market 2010

AZERBAIJAN:in prospect April 2011

Page 2: Azerbaijan pharmaceutical market 2010

The population of Azerbaijan was 8.58 million in 2007, with approximately half living in urban areas (see Table 1.1). The majority of the population is Muslim but the state is secular and other religions practised include Russian Orthodoxy and Armenian Orthodoxy. The state language is Azeri, which is linguistically very close to Turkish, and Russian is also widely spoken as a Soviet legacy. According to the last published census (held in 1999; the next was undertaken in 2009), 90.6% of the population were ethnic Azerbaijani, 2.2% were Lezgins, 1.8% were Russians, 1.5% were Armenians and the remaining 3.9% was made up of other minority groups including Avar, Talysh, Turkish, Georgian and Tatar. However, demographic estimates are somewhat imprecise because of the population displacement resulting from the war with Armenia. According to official estimates, there are nearly one million refugees and internally displaced persons (IDPs) in Azerbaijan, which constitute the most marginalized stratum in society (United Nations Development Programme, 2007)

Azerbaijan is located in the south Caucasus on the western coast of the Caspian Sea. The country is divided into two parts, the main territory of Azerbaijan and the exclave autonomous republic of Nakhichevan, which are separated by Armenian territory. The country has considerable mineral wealth, including oil and gas reserves. At the beginning of the 20th century, Azerbaijan supplied almost half of the world’s oil, and oil has remained central to the country’s economy into the 21st century. In 2007, the oil sector accounted for more than 50% of gross domestic product (GDP) and 80% of exports. Azerbaijan has a very stable political environment. President Ilham Aliyev has been in

power since 2003 when his father (Heydar Aliyev) stepped down because of ill health after 10 years in power since independence.

The main causes of adult mortality are essentially noncommunicable, with circulatory diseases predominating. Nevertheless, the prevention of communicable diseases, particularly tuberculosis (TB), remains a significant health issue. Reducing the burden of infant and maternal mortality has also been recognized as a key health priority in the country.

Azerbaijan inherited an extensive and highly centralized Semashko system at independence, and many of its key features have been retained. The formal structure of the health system is highly centralized and hierarchical and most decisions about key health policy initiatives are made at the national level. The Ministry of Health formally has ultimate responsibility for the management of the health system, but it has limited means to influence health care providers at the local level as they are financially dependent on the local district health authorities or the village authorities for smaller rural services. The district authorities and the administration of the central district hospital have direct managerial responsibilities for health providers in their area. There is also considerable parallel health service provision outside the influence of the Ministry of Health, as providers are subordinated to and financed through other line ministries or state enterprises. The private sector is licensed by the Ministry of Health but is otherwise completely independent, and private service provision is a growing feature of the system.

Azerbaijan Pharmaceutical Market

Azerbaijan:in prospect is available at Euros 145.00

The access to the pharmaceutical marketplace of any region is always paired with risks, challenges and political, financial and economical factors specific to each region.

To know more about our report or to discuss this topic further please do not hesitate to contact us Tel/Fax: +38 044 206 17 17/18 e-mail: [email protected]

Page 3: Azerbaijan pharmaceutical market 2010

Azerbaijan:in prospect

Azerbaijan:in prospect © 2011 SMD All information contained in this publication is copyrighted in the name of SMD (Support in Market Development), and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher.

DISCLAIMER All information contained in this publication has been researched and compiled from sources believed to be accurate and reliable at the time of publishing. However, SMD accepts no liability whatsoever for any loss or damage resulting from errors, inaccuracies or omissions affecting any part of the publication. All information is provided without warranty, and SMD makes no representation of warranty of any kind as to the accuracy or completeness of any information hereto contained.

EECCA: Region Features

Economic Development

Pharmaceutical Market: Executive Summary

Pharmaceutical Market: Main Features

Pharmaceutical Market: Structure

Per capita expenses

Azerbaijan

Country profile

Economy

Healthcare system features

Healthcare system funding

Azerbaijan: Pharma Market

Key data

Main features

ATC 1 dynamics. Retail total, USD

ATC 1 dynamics. Retail total, Units

ATC 1 dynamics. Rx segment, USD

ATC 1 dynamics. Rx segment, Units

ATC 1 dynamics. OTC segment, USD

ATC 1 dynamics. OTC segment, Units

Leading corporations. Retail total, USD

Leading corporations. Retail total, Units

Leading corporations. Rx segment, USD

Leading corporations. Rx segment, Units

Leading corporations. OTC segment, USD

Leading corporations. OTC segment, Units

Azerbaijan: Forecast for 2011-2013

Retail Segment, USD

Page 4: Azerbaijan pharmaceutical market 2010

AZERBAIJAN:in prospect April 2011

SMD (Support in Market Development) - is a leading provider of market research, sales management and forecasting services to the pharmaceutical industry. Researches of: · Pharmaceutics establishments' purchase and sale audit · Hospital establishments' purchase audit · Second distribution audit · Import medicine analyses · Doctor prescription analyses · Ad Hoc research · Analytical services

Ukraine, 03680 Bojenko str., 86i, Kiev

Tel/Fax: +38 044 206 17 17/18 e-mail: [email protected] http://www.smd.net.ua